These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 7970709

  • 1. Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant.
    Rapp UR, Troppmair J, Beck T, Birrer MJ.
    Oncogene; 1994 Dec; 9(12):3493-8. PubMed ID: 7970709
    [Abstract] [Full Text] [Related]

  • 2. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
    Kolch W, Heidecker G, Troppmair J, Yanagihara K, Bassin RH, Rapp UR.
    Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
    [Abstract] [Full Text] [Related]

  • 3. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M, Kishida S, Murai H, Hinoi T, Kikuchi A.
    Cancer Res; 1996 May 15; 56(10):2387-92. PubMed ID: 8625316
    [Abstract] [Full Text] [Related]

  • 4. Imbalanced expression of cellular nuclear oncogenes caused by v-sis/PDGF-2.
    Sonobe MH, Bravo R, Armelin MS.
    Oncogene; 1991 Sep 15; 6(9):1531-7. PubMed ID: 1923519
    [Abstract] [Full Text] [Related]

  • 5. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV, Reynolds ER, Shao H, Grana TM, Chan TO, Andres DA, Cox AD.
    Oncogene; 2000 Sep 28; 19(41):4685-94. PubMed ID: 11032018
    [Abstract] [Full Text] [Related]

  • 6. v-erbA cooperates with bFGF in neuroretina cell transformation.
    Garrido C, Li RP, Samarut J, Gospodarowicz D, Saule S.
    Virology; 1993 Feb 28; 192(2):578-86. PubMed ID: 7678474
    [Abstract] [Full Text] [Related]

  • 7. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
    Heinicke T, Radziwill G, Nawrath M, Rommel C, Pavlovic J, Moelling K.
    Cancer Gene Ther; 2000 May 28; 7(5):697-706. PubMed ID: 10830717
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mechanism of action of a dominant-negative mutant of c-Jun.
    Brown PH, Chen TK, Birrer MJ.
    Oncogene; 1994 Mar 28; 9(3):791-9. PubMed ID: 8108121
    [Abstract] [Full Text] [Related]

  • 11. v-raf confers CSF-1 independent growth to a macrophage cell line and leads to immediate early gene expression without MAP-kinase activation.
    Büscher D, Dello Sbarba P, Hipskind RA, Rapp UR, Stanley ER, Baccarini M.
    Oncogene; 1993 Dec 28; 8(12):3323-32. PubMed ID: 8247534
    [Abstract] [Full Text] [Related]

  • 12. v-myc and v-raf act synergistically to induce B-cell tumors in pristane-primed adult BALBC mice.
    Kurie JM, Morse HC, Principato MA, Wax JS, Troppmair J, Rapp UR, Potter M, Mushinski JF.
    Oncogene; 1990 Apr 28; 5(4):577-82. PubMed ID: 2183159
    [Abstract] [Full Text] [Related]

  • 13. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
    Cuadrado A, Bruder JT, Heidaran MA, App H, Rapp UR, Aaronson SA.
    Oncogene; 1993 Sep 28; 8(9):2443-8. PubMed ID: 8361757
    [Abstract] [Full Text] [Related]

  • 14. C127 cells resistant to transformation by tyrosine protein kinase oncogenes.
    Cuadrado A, Talbot N, Barbacid M.
    Cell Growth Differ; 1990 Jan 28; 1(1):9-15. PubMed ID: 2150330
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J, Jiang B, Coffey RJ, Barnard J.
    Mol Cancer Res; 2004 Apr 28; 2(4):233-41. PubMed ID: 15140945
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.